CeQur

  • CeQur Announces Publication of Data Demonstrating PAQ Insulin Delivery Device Reduces Barriers to Insulin Therapy


    To read the Press Release, click here.
    To read the abstract, click here.
  • New Data Show CeQur Simple Insulin Delivery Device Improves Glycemic Control Among People with Type 2 Diabetes


    To read the Press Release, click here.
  • CeQur Appoints Douglas Lawrence Chief Executive Officer


    To read the Press Release, click here.
  • Diabetes Care Publishes Data Demonstrating PAQ Insulin Delivery Device Could Help People with Type 2 Diabetes Overcome Barriers to Insulin Adherence and Improve Clinical Outcomes


    To read the Press Release, click here.
    To read the abstract, click here.
  • CeQur to Present at the 32nd Annual J.P. Morgan Healthcare Conference


    To read the article, click here.
  • CeQur Corporation Helps Lead 2013 Central Massachusetts American Diabetes Association Fundraising Effort


    To read the article, click here.
  • Data Demonstrating Potential Benefits of Simple Insulin Delivery Device Presented at European Association for the Study of Diabetes Annual Meeting


    To read the article, click here.
  • New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People with Type 2 Diabetes


    To read the article, click here.
  • CeQur Announces Positive Results from Study Evaluating Simple Insulin Delivery Device Among People with Type 2 Diabetes


    To read the article, click here.
  • CeQur Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides


    To read the article, click here.
  • CeQur Receives CE Mark for PAQ Insulin Delivery Device


    To read the article, click here.
  • CeQur Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People with Type 2 Diabetes


    To read the article, click here.
  • CeQur SA Initiates Clinical Study of Simple Insulin Delivery Device for People with Type 2 Diabetes


    To read the article, click here.
  • CeQur Establishes Wales subsidiary


    To read the article, click here.
  • CeQur SA Closes $27 Million Series B Financing


    To read the article, click here.